The wide use of skin allografts
Giladi, A.; Neuman, Z.
Harefuah 80(11): 594-596
1971
ISSN/ISBN: 0017-7768 PMID: 4945698 Document Number: 41061
Document emailed within 1 workday
Related Documents
Vŭglenova, E.; Kamenova, V. 1991: Skin allografts from donors in a wide range of ages Khirurgiia 44(4): 30-33Klaue, P.; Jolley, W.B.; Hinshaw, D.B. 1971: Effect of incubating skin in steroid suspension (triamcinolone acetonide) on survival of skin allografts in rabbits Transplantation Proceedings 3(1): 823-825
Lim, S.M.; Li, S.Q.; Poh, L.H.; Chong, T.W. 1994: Difficulty in the induction of tolerance to vascularised skin allografts Transplantation Proceedings 26(4): 1957
Yoshimura, R.; Chargui, J.; Aitouche, A.; Veyron, P.; Touraine, J.L. 2000: Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes Transplantation 69(7): 1452-1457
Capel, P.J.; Tamboer, W.P.; de Waal, R.M.; Jansen, J.L.; Koene, R.A. 1979: Passive enhancement of mouse skin allografts by alloantibodies is Fc dependent Journal of Immunology 122(2): 421-425
Warren, R.P.; Lofgreen, J.S.; Steinmuller, D. 1973: Differential survival of heart and skin allografts in inbred rats Transplantation Proceedings 5(1): 717-719
Graham, W.P.; Hamilton, R.W.; Lehr, H.B. 1971: Versatility of skin allografts: desirability of a viable frozen tissue bank Journal of Trauma 11(6): 494-501
Floersheim, G.L.; Brune, K. 1971: Tolerance to skin allografts by immunosuppressive "pulse" of methylhydrazine derivatives and antilymphocyte serum Transplantation Proceedings 3(1): 688-692
Capel, P.J.; de Waal, R.M.; Démant, P.; Koene, R.A. 1981: Enhancement and antibody-mediated rejection of mouse skin allografts with anti-H-2K, H-2D, H-2L antibodies Transplantation Proceedings 13(1 Part 1): 649-653
Shivatcheva, T.M. 1988: Survival of skin allografts in European ground squirrels, Spermophilus citellus L., during hibernation Folia Biologica 36(3-4): 213-221
Holán, V.; Hasek, M. 1985: Prolonged or permanent survival of skin allografts induced by monoclonal antibodies against lymphocyte subpopulations Folia Biologica 31(1): 50-58
Nouza, K.; Hilgert, I.; Nĕmec, M.; Kristofová, H. 1972: Indirect evidence of two adverse components of the humoral response to skin allografts as revealed in ALS-suppressed mice Folia Biologica 18(4): 264-269
Sakai, A.; Yakushiji, K.; Mashimo, S. 1980: Lymphocyte stimulation by allogeneic tissue cells in rats: with special reference to differential survival of skin and kidney allografts Transplantation Proceedings 12(3 Suppl. 1): 74-81
Smith, D.M.; McKisic, M.; Stuart, F.P.; Fitch, F.W. 1989: T-lymphocyte subsets: major histocompatibility antigens rejection of H-2K or H-2i region disparate skin allografts by either Lyt-2+ or L3T4+ T-lymphocyte subset Transplantation Proceedings 21(1 Part 1): 162-164
Harada, M.; Omoto, K.; Kimura, G.; Nomoto, K. 1995: Priming with donor spleen cells and activated B cells can induce prolonged survival of class I-disparate skin allografts in cyclophosphamide-treated mice Transplantation 60(5): 517-519
Gorczynski, R.M.; Wojcik, D. 1994: A role for nonspecific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization or transfusion Journal of Immunology 152(4): 2011-2019
Bishop, G.A.; Sun, J.; Johnston, B.; Sheil, A.G.; McCaughan, G.W. 1995: Comparison of immune changes in rejecting rat cardiac allografts with tolerant cardiac allografts secondary to liver grafts Transplantation Proceedings 27(3): 2161-2162
Bhan, A.K.; Mihm, M.C.; Dvorak, H.F. 1982: T cell subsets in allograft rejection. in situ characterization of T cell subsets in human skin allografts by the use of monoclonal antibodies Journal of Immunology 129(4): 1578-1583
Mottram, P.L.; Mirisklavos, A.; Clunie, G.J. 1985: Cyclosporine and murine responses to alloantigens: effects of cyclosporine and donor-specific transfusions on delayed hypersensitivity reactions and murine skin allografts Transplantation Proceedings 17(2): 1646-1649
Dy, M.; Lebel, B. 1983: Skin allografts generate an enhanced production of histamine and histamine-producing cell-stimulating factor (HCSF) by spleen cells in response to T cell mitogens Journal of Immunology 130(5): 2343-2347